FCN
FTI ConsultingCAI scenario view
RankAlpha Sentiment CodexThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Operating evidence is mixed-positive: record revenue, strong quarterly operating cash flow, reaffirmed revenue guidance, and a positive deterministic prior are offset by margin compression and lower net income. The anchor price of $141 is below the packet's $175.50 median target, but the missing analyst count and revision history make that signal tentative. Recent-news entries are false-positive ticker matches and were excluded. Social coverage, options skew, short interest, employee rating, and reliable 30-day news sentiment were unavailable; their zero values indicate missing evidence rather than neutral or favorable readings.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The next quarterly report should test whether revenue growth can translate into renewed operating leverage. Second-quarter revenue rose 5.3% to a record $993.5 million, but adjusted EBITDA declined to $104.5 million and adjusted EBITDA margin contracted to 10.5% from 11.8%; adjusted EPS was $2.16 versus $2.13 a year earlier. The company reaffirmed revenue guidance while updating 2026 EPS guidance to $8.70-$9.30 and introducing adjusted EPS guidance of $9.10-$9.70 [#SEC-8K-2026-07-31].
The board authorized an additional $370 million for share repurchases on June 3, 2026. Continued deployment at depressed prices could support per-share value, but actual timing and volume remain discretionary [#SEC-8K-2026-07-31].
Management attributes the platform's resilience to multiyear investment in talent and sees increasingly relevant capabilities as clients confront disruption. A durable rerating requires Corporate Finance, Technology, and Forensic and Litigation Consulting growth to persist while higher direct costs, SG&A, interest expense, and extraordinary litigation-related costs normalize [#SEC-8K-2026-07-31].
Recommendation
No formal recommendation provided.

